Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generating property-matched decoy molecules using deep learning
Fergus Imrie, A.R. Bradley, Charlotte M. Deane
Bioinformatics (2021) Vol. 37, Iss. 15, pp. 2134-2141
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

A practical guide to machine-learning scoring for structure-based virtual screening
Viet‐Khoa Tran‐Nguyen, Muhammad Junaid, Saw Simeon, et al.
Nature Protocols (2023) Vol. 18, Iss. 11, pp. 3460-3511
Closed Access | Times Cited: 37
Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity
Xuehui Long, Sulin Zhang, Yuliang Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 525-536
Closed Access | Times Cited: 12
Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening
Clara Blanes‐Mira, Pilar Fernández-Aguado, Jorge de Andrés-López, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 175-175
Open Access | Times Cited: 39
Yes SIR! On the structure–inactivity relationships in drug discovery
Edgar López‐López, Eli Fernández‐de Gortari, José L. Medina‐Franco
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2353-2362
Closed Access | Times Cited: 37
Open-Source Machine Learning in Computational Chemistry
Alexander Hagg, Karl N. Kirschner
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 15, pp. 4505-4532
Open Access | Times Cited: 23
The pursuit of accurate predictive models of the bioactivity of small molecules
Karina Martínez‐Mayorga, José Guadalupe Rosas-Jiménez, Karla Gonzalez-Ponce, et al.
Chemical Science (2024) Vol. 15, Iss. 6, pp. 1938-1952
Open Access | Times Cited: 9
Current strategies to address data scarcity in artificial intelligence-based drug discovery: A comprehensive review
Amit Gangwal, Azim Ansari, Iqrar Ahmad, et al.
Computers in Biology and Medicine (2024) Vol. 179, pp. 108734-108734
Closed Access | Times Cited: 9
Inactive-enriched machine-learning models exploiting patent data improve structure-based virtual screening for PDL1 dimerizers
Pablo Gómez-Sacristán, Saw Simeon, Viet‐Khoa Tran‐Nguyen, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 7
AlphaFold and what is next: bridging functional, systems and structural biology
Kacper Szczepski, Łukasz Jaremko
Expert Review of Proteomics (2025)
Closed Access
Recent progress on the prospective application of machine learning to structure-based virtual screening
Ghita Ghislat, Taufiq Rahman, Pedro J. Ballester
Current Opinion in Chemical Biology (2021) Vol. 65, pp. 28-34
Open Access | Times Cited: 47
Investigating the conformational landscape of AlphaFold2-predicted protein kinase structures
Carmen Al-Masri, Francesco Trozzi, Shu-Hang Lin, et al.
Bioinformatics Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Beware of Simple Methods for Structure-Based Virtual Screening: The Critical Importance of Broader Comparisons
Viet‐Khoa Tran‐Nguyen, Pedro J. Ballester
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 5, pp. 1401-1405
Open Access | Times Cited: 15
In silico off-target profiling for enhanced drug safety assessment
Jin Liu, Yike Gui, Jingxin Rao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2927-2941
Open Access | Times Cited: 4
Generic protein–ligand interaction scoring by integrating physical prior knowledge and data augmentation modelling
Duanhua Cao, Geng Chen, Jiaxin Jiang, et al.
Nature Machine Intelligence (2024) Vol. 6, Iss. 6, pp. 688-700
Closed Access | Times Cited: 4
SCORCH: Improving structure-based virtual screening with machine learning classifiers, data augmentation, and uncertainty estimation
Miles McGibbon, Sam Money-Kyrle, Vincent Blay, et al.
Journal of Advanced Research (2022) Vol. 46, pp. 135-147
Open Access | Times Cited: 24
TocoDecoy: A New Approach to Design Unbiased Datasets for Training and Benchmarking Machine-Learning Scoring Functions
Xujun Zhang, Chao Shen, Ben Liao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7918-7932
Closed Access | Times Cited: 22
Evaluation of AlphaFold2 Structures for Hit Identification across Multiple Scenarios
Shukai Gu, Yuwei Yang, Yihao Zhao, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 9, pp. 3630-3639
Closed Access | Times Cited: 3
Drug repurposing in silico screening platforms
Jonathan G. L. Mullins
Biochemical Society Transactions (2022) Vol. 50, Iss. 2, pp. 747-758
Closed Access | Times Cited: 18
Target-Specific Machine Learning Scoring Function Improved Structure-Based Virtual Screening Performance for SARS-CoV-2 Drugs Development
Muhammad Tahir ul Qamar, Xi-Tong Zhu, Ling‐Ling Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11003-11003
Open Access | Times Cited: 18
Reducing false positive rate of docking-based virtual screening by active learning
Lei Wang, Shaohua Shi, Hui Li, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 8
Innovative Integration of Butina Clustering with Ensemble Learning Techniques for the Refined Pharmacophore Modeling of Apelin Receptor Agonists: A High-Impact Computational Approach
Xuan-Truc Dinh Tran, Tieu-Long Phan, Van-Thinh To, et al.
(2024)
Open Access | Times Cited: 2
Integrated Computational Approaches for Drug Design Targeting Cruzipain
Aiman Parvez, Jeong‐Sang Lee, Waleed Alam, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3747-3747
Open Access | Times Cited: 2
Novel machine learning approach toward classification model of HIV-1 integrase inhibitors
Tieu-Long Phan, The-Chuong Trinh, Van-Thinh To, et al.
RSC Advances (2024) Vol. 14, Iss. 21, pp. 14506-14513
Open Access | Times Cited: 2
Do Molecular Fingerprints Identify Diverse Active Drugs in Large-Scale Virtual Screening? (No)
Vishwesh Venkatraman, Jeremiah Gaiser, Daphne Demekas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 992-992
Open Access | Times Cited: 2
Structure-based virtual screening for PDL1 dimerizers: Evaluating generic scoring functions
Viet‐Khoa Tran‐Nguyen, Saw Simeon, Muhammad Junaid, et al.
Current Research in Structural Biology (2022) Vol. 4, pp. 206-210
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top